1) Support corporate tax policies which protect US research and manufacturing jobs, including issues related to US corporate tax rate, transfer pricing and patent box. Advocacy to reform IPAB to ensure patient access to medically necessary therapies. Patent Reform -- S. 23 and HR 1249 -- Support for modernizing the patent system while ensuring the ongoing strength and value of intellectual property for biotechnology, with a specific focus on damages provisions, inequitable conduct, and post-grant/second window.  Opposition to inclusion of patent settlements legislation in appropriations bill. 1) Implementation of biosimilars regulations to support incentives for innovation and second generation therapies.
2) Support for passage of the PDUFA reathorization to increase transparency and efficiency of the drug review process at FDA
TAX - Taxation/Internal Revenue Code MMM - Medicare/Medicaid CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of
BIOGEN
601 PENNSYLVANIA AVENUE, NW #720, WASHINGTON, DC, 20004, US
KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committe)
Staff, House Ways and Means Committee Staff, Senate HELP Committee Staff, House Ways and Means Committee Staff, Senate HELP Committee Staff, House Ways and Means Committee Staff, Senate HELP Committee Staff, House Ways and Means Committee Staff, Senate HELP Committe